Key Insights

Highlights

Success Rate

80% trial completion

Clinical Risk Assessment

Based on trial outcomes

High Risk

Score: 62/100

Termination Rate

11.8%

2 terminated out of 17 trials

Success Rate

80.0%

-6.5% vs benchmark

Late-Stage Pipeline

12%

2 trials in Phase 3/4

Results Transparency

25%

2 of 8 completed with results

Key Signals

2 with results80% success

Data Visualizations

Phase Distribution

11Total
Not Applicable (8)
P 1 (1)
P 3 (2)

Trial Status

Completed8
Recruiting3
Unknown3
Terminated2
Not Yet Recruiting1

Trial Success Rate

80.0%

Benchmark: 86.5%

Based on 8 completed trials

Clinical Trials (17)

Showing 17 of 17 trials
NCT04289909Not ApplicableCompleted

Identification of Retinal Perivascular Inflammation in Patients With Multiple Sclerosis Using Adaptive Optics (RETIMUS)

NCT07508514Not Yet Recruiting

Early Temporal Dynamics of Optic Nerve Sheath Diameter After Therapy in GCA

NCT06841575Not ApplicableRecruiting

Advancing Pediatric Retinal Imaging With Auto-aligned OCT

NCT06139523Recruiting

Optimize Pediatric OCT Imaging

NCT06390579Completed

Building Research With Artificial Intelligence in Neuro-Ophthalmology

NCT05626426Not ApplicableRecruiting

Electrical Stimulation for the Treatment of Optic Neuropathies

NCT04125043Completed

Accuracy of the Red Reflex Test in the Pediatric Population

NCT05130385Unknown

High Resolution Optical Coherence Tomography

NCT02582164Not ApplicableCompleted

Long-Working Distance OCT for Children

NCT04634383Not ApplicableUnknown

A Phase I Feasibility Study of an Intracortical Visual Prosthesis (ICVP) for People With Blindness

NCT04891211Not ApplicableCompleted

Retinal Changes in Vitamin D Deficiency

NCT01270126Not ApplicableCompletedPrimary

Trial of Alternating Current Stimulation in Optic Neuropathy

NCT02376881Phase 3UnknownPrimary

Erythropoietin in Methanol Associated Optic Neuropathy: A Phase-2 Clinical Trial (EPO-MAON Study)

NCT01404247Phase 1Completed

Spectral Domain Optical Coherence Tomography Imaging of the Eyes of Neonates

NCT01280877Not ApplicableCompletedPrimary

Paraorbital-Occipital Alternating Current Stimulation Therapy for Optic Neuropathy (MCT_optnerve)

NCT00359632Phase 3TerminatedPrimary

Study to Evaluate Eye Function in Patients Taking Linezolid for Six Weeks or Greater

NCT01422525Terminated

Changes of the Peripapillary Retinal Nerve Fiber Layer After Filtration Surgery in Glaucoma Patients

Showing all 17 trials

Research Network

Activity Timeline